C/EBPβ Phosphorylation Signaling and Lung Injury in Mice
Author Information
Author(s): Martina Buck, Mario Chojkier, Regine Schneider-Stock
Primary Institution: Department of Medicine, VA Healthcare Center, San Diego, California, United States of America
Hypothesis
The RSK-C/EBPβ-Thr217 phosphorylation pathway may be critical for lung injury and fibrogenesis.
Conclusion
Blocking the RSK-C/EBPβ phosphorylation pathway reduces lung injury and fibrosis in mice.
Supporting Evidence
- Mice expressing the C/EBPβ-Ala217 transgene showed reduced lung injury and fibrosis.
- Phosphorylation of C/EBPβ on Thr217 was linked to increased lung fibrosis.
- Blocking C/EBPβ phosphorylation with a peptide reduced lung injury in treated mice.
- Inflammatory cytokine levels were lower in mice treated with the C/EBPβ peptide.
Takeaway
Scientists found that a specific protein modification helps mice develop lung injury and fibrosis, and blocking this modification can prevent those issues.
Methodology
Mice were treated with Bleomycin to induce lung injury, and various assays were performed to assess lung fibrosis and injury.
Potential Biases
Potential bias in interpreting results due to the use of a single animal model.
Limitations
The study primarily used a mouse model, which may not fully replicate human lung fibrosis.
Participant Demographics
Mice of identical genetic background (FVB strain) were used.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website